Study explores synthetic cannabinoid for cancer anorexia
Artelo Biosciences is investigating the viability of its novel cannabinoid product as a solution to treat cancer-related anorexia in oncology patients. Anyone who’s had to watch a loved one deal with a cancer diagnosis—or has suffered from the disease themselves—knows loss of weight, body mass, appetite, and other problems are frequent effects. Artelo Biosciences recently received the go-ahead to test its unique cannabinoid to treat cancer-associated anorexia in a trial, potentially giving hope to cancer patients. Artelo’s drug reportedly serves as a full a...